Provided by Tiger Trade Technology Pte. Ltd.

CSL LIMITED

175.990
-2.250-1.26%
Volume:442.41K
Turnover:74.89M
Market Cap:84.28B
PE:-22.75
High:179.980
Open:178.030
Low:175.600
Close:178.240
52wk High:216.734
52wk Low:88.830
Shares:478.91M
Float Shares:478.91M
Volume Ratio:1.37
T/O Rate:0.09%
Dividend:4.22
Dividend Rate:2.40%
EPS(TTM):-7.736
EPS(LYR):-7.736
ROE:-15.83%
ROA:7.26%
PB:3.94
PE(LYR):-22.75

Loading ...

Australia's CSL Slips on Trading Ex-Dividend, Among Benchmark's Top Percentage Losers

Reuters
·
Sep 09

CitiFirst CSL SFIs Dividend Estimated Amount-CTW

Reuters
·
Sep 08

CSL Says Vanguard Group Raises Stake

MT Newswires Live
·
Sep 04

Australian Shares Rise as Miners, Banks Gain on Lower Oil, Bond Yields

Reuters
·
Sep 03

Black Box Warning on CSL's Injectafer Unlikely to Change Much

Dow Jones
·
Sep 03

CSL Bulls Don't See Large Impact from U.S. Pricing Deals

Dow Jones
·
Sep 02

Global Pharma Companies That Have Publicly Announced Trump Drug Pricing Agreements

Reuters
·
Sep 01

CSL's U.S. Agreements Remove Two Stock Overhangs

Dow Jones
·
Sep 01

ASX Preview: Australian Shares to Fall as Oil Surges on US-Iran Conflict; Ausgold Fiscal 2026 Loss Narrows

MT Newswires Live
·
Sep 01

CSL Secures US Agreements to Cut Medicine Costs, Expand Manufacturing

MT Newswires Live
·
Sep 01

CSL Signs U.S. Government Agreements to Lower Drug Prices for Medicaid

Reuters
·
Sep 01

CSL Limited-Agreements with U.S. on Drug Prices and Manufacturing

THOMSON REUTERS
·
Sep 01

Trump Administration Announces Drug Pricing Deals with CSL, Astellas and Others

Reuters
·
Sep 01

CSL Ltd: Agreements Support Lower Prices for CSL Therapies and Reflect CSL's $1.5 Billion Plan to Expand Its U.S. Manufacturing Capacity in Illinois

THOMSON REUTERS
·
Sep 01

CSL Enters Agreements with the U.S. Government to Lower Drug Prices and Support Investment in U.S. Manufacturing

THOMSON REUTERS
·
Sep 01

CSL : Agreements Provide CSL with Additional Certainty Regarding Exposure to U.S. Drug Pricing & Certain Section 232 Tariffs

THOMSON REUTERS
·
Sep 01

CSL : Entered into Onshoring Agreement with the U.S. Department of Commerce

THOMSON REUTERS
·
Sep 01

CSL : Project to Substantially Increase Co's Ability to Produce Immunoglobulins & Albumin for People with Rare Diseases & Serious Conditions

THOMSON REUTERS
·
Sep 01

CSL Ltd: Project is Expected to Create at Least 300 New Pharmaceutical Manufacturing Jobs and Approximately 800 Construction and Related Jobs

THOMSON REUTERS
·
Sep 01

CSL : Does not Anticipate Any Material Impact During Fiscal Year 2027

THOMSON REUTERS
·
Sep 01